Group 1 - The company, Zhejiang Taimei Medical Technology Co., Ltd., announced a sudden change in its financial leadership, with CFO Jiang Chengwen resigning due to personal reasons and Wang Wei appointed as the new CFO [1] - Wang Wei, aged 36, has over ten years of experience in capital market transactions and has held various senior positions in financial institutions, including Credit Suisse and Huadeng Capital [2] - The company has reported continuous losses for 11 years since its establishment in 2013, with a revenue of 551 million yuan in 2024, a year-on-year decrease of 3.8%, and a net loss of 217 million yuan [3] Group 2 - The company's workforce has significantly reduced from 1,490 full-time employees at the end of 2021 to 627 by the end of 2024, indicating a nearly 60% reduction in staff [3] - Cost-cutting measures have led to a 40% decrease in employee welfare expenses, resulting in a gross margin increase of 9.6 percentage points to 40.8% in 2024 [3] - Despite the improvement in gross margin, the company's R&D investment has nearly halved, raising concerns about its long-term competitiveness in the market [3]